Haplo stem cell transplantation innovations are set to revolutionize cancer treatment in 2025, from personalized therapies to AI-powered diagnostics.

HAPLO STEM CELL TRANSPLANT: 

A NEW HOPE

HAPLOIDENTICAL DONORS EXPLAINED

Haploidentical donors share half of their HLA markers with the patient, often being parents, siblings, or children.

EXPANDING THE DONOR POOL

Haplo transplants allow family members who are not a perfect match to donate, significantly increasing donor availability.

FIRST DEGREE RELATIVES AS IDEAL DONORS

Parents, siblings, and children are often the best haploidentical donors due to their genetic connection.

GLOBAL GROWTH OF HAPLO TRANSPLANTS

The prevalence of haploidentical transplants is increasing worldwide, supported by advancements in medical technology.

COMPARABLE SURVIVAL RATES

Recent studies show that one-year survival rates for haploidentical transplants approach 80%, similar to fully matched transplants.

MANAGING UNIQUE COMPLICATIONS

Graft versus host disease (GVHD) is a significant risk; however, strategies like post transplant cyclophosphamide help mitigate it.

INNOVATIONS IMPROVING OUTCOMES

Innovative techniques, such as T-cell depletion and new immunosuppressive strategies, are enhancing the effectiveness of haplo transplants.

Stories

More

HOW QUICKLY DOES A LIVER TUMOR GROW?

CANCER TREATMENT BREAKTHROUGHS COMING IN 2025